Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine
Anaplastic Oligoastrocytoma
Jonsson Comprehensive Cancer CentervaccinePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Anaplastic Oligoastrocytoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Camustine Shandong Lanjin Pharmaceuticals Co.,Ltd | Phase 3 | B |
Α-Ifn Sun Yat-sen University | Phase 3 | B |
Β-Elemene Sun Yat-sen University | Phase 3 | B |
Dendritic Cells Pulsed With Tumor Lysate Jonsson Comprehensive Cancer Center | Phase 2 | B |
Nintedanib Patrick Y. Wen, MD | Phase 2 | B |
View all 36 →
Same molecule, other indications
Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →